Camber Pharma Launches Generic Sensipar®

Piscataway, NJ, December 10, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Cinacalcet Tablets, which is the generic version of Sensipar®.
Cinacalcet Tablets are used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.
Cinacalcet Tablets are available from Camber in 30, 60 and 90mg- 30 count bottles.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection